Header
Header
Article

New patent for Azurity drug KATERZIA – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Azurity drug KATERZIA


Annual Drug Patent Expirations for KATERZIA

Katerzia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

KATERZIA drug price trends.

This drug has ten patent family members in six countries.

The generic ingredient in KATERZIA is amlodipine benzoate. One supplier is listed for this compound. Additional details are available on the amlodipine benzoate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Azurity drug KATERZIA



Source link

Back to top button